The illegal cannabis farms discovered and closed down in the Netherlands last year stole a total of around 60 million euros in electricity, according to Netbeheer Nederland.
Cannabis has the potential to modulate some of the most common and debilitating symptoms of cancer and its treatments, including nausea and vomiting, loss of appetite, and pain. However, the dearth of scientific evidence for the effectiveness of cannabis in treating these symptoms in patients with cancer poses a challenge to clinicians in discussing this option with their patients.
The Canadian government legalized non-medical cannabis use by adults in October 2018 in order to minimize associated harms and re-direct profits from criminals.
International personal care giant Colgate Palmolive has announced that it is set to acquire CBD oral care company, Hello Products. It is the most recent in a wave of established health brands entering the CBD space through acquisition.
Cannabidiol (CBD), a major metabolite of Cannabis sativa, is popularized as a medicinal product, with potential for analgesic, anti-inflammatory and antioxidant effects. CBD may hold promise as a treatment in rheumatic diseases, but evidence to date remains preclinical. Preclinical effects on pain and inflammation is encouraging, but clinical study is lacking with only a single study in knee osteoarthritis reporting promising effect on symptoms.
Peterborough’s first legal cannabis store is about to open.
Concerns looming over coronavirus impact on cannabis industry, but some US firms could gain from fallout.
Marijuana and hemp companies of all stripes – from growers to retailers – are likely to join other global industries feeling the fallout from the coronavirus outbreak.
This review was undertaken to survey recent literature for research reports and comprehensive clinical reviews addressing the pharmacologic management of nausea and vomiting (N&V) in advanced cancer. The goal was to integrate findings in a comprehensive article that incorporates palliative care concepts into antiemetic treatment.
New data from Kryptoszene has revealed the cannabis industry is expected to see an increase in sales up to 374% until 2023. In only three years, a rise in demand for CBD-products will most likely result in a turnover of $23.7bn in the United States.
Therapeutic use of cannabis and cannabinoids: an evidence mapping and appraisal of systematic reviews.
Medical cannabis, or cannabinoid-based products, continues to grow in popularity globally, driving the evolution of regulatory access frameworks; cancer patients and caregivers often rely on guidance from their physicians regarding cannabinoid-based treatments. But the majority of healthcare practitioners still feel unprepared and insufficiently informed to make reasonable, evidence-based recommendations about medical cannabis.